Literature DB >> 8556508

Prenatal diagnosis of heterozygous deficiency of the second component of complement.

K E Sullivan1, J A Winkelstein.   

Abstract

Genetically determined C2 deficiency predisposes an individual to recurrent and invasive bacterial infections as well as a variety of rheumatic diseases. Most C2-deficient individuals carry the same 28-bp deletion in the sixth exon of the C2 gene. The present article reports the first prenatal analysis of a sibling of a C2-deficient patient; the sibling was found to be a heterozygous carrier of the 28-bp deletion of C2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556508      PMCID: PMC368348          DOI: 10.1128/cdli.1.5.606-607.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  5 in total

1.  Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing.

Authors:  C A Johnson; P Densen; R K Hurford; H R Colten; R A Wetsel
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

Review 2.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

3.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

Review 4.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus.

Authors:  K E Sullivan; M A Petri; B J Schmeckpeper; R H McLean; J A Winkelstein
Journal:  J Rheumatol       Date:  1994-06       Impact factor: 4.666

  5 in total
  1 in total

Review 1.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.